CDMO News AI + Digital Maturity in Contract ManufacturingExclusive Report External Manufacturing Leaders BostonRegister CDMO Live Americas 2026 Early BirdAgenda Download CDMO News WuXi XDC Announces $885 Million Strategic ADC Collaboration with Earendil Labs WuXi XDC Announces $885 Million Strategic ADC Collaboration with Earendil Labs IDT Biologika, SK bioscience and Vaxxas Advance Needle-Free Influenza Vaccines for Europe Quotient Sciences Extends Commercial Supply Partnership with Ipsen for FOP Treatment Scinai Immunotherapeutics Secures NIS 5 Million IIA Grant to Expand Robotic Fill & Finish Platform Charles River Laboratories Updates 2026 Guidance Following Planned Divestitures Cellipont Bioservices and Soter Bio Launch U.S.-Based Integrated RNA-to-Cell Therapy Platform C-Ray Therapeutics Achieves AAALAC Full Accreditation for Radiopharmaceutical CRDMO Facility AtomVie Global Radiopharma Supplies First Patient Dose in Phase 1/2a Study of 177Lu-BetaBart (RV-01) Avid Bioservices Opens 78,000 Square Foot Early Phase Center of Excellence in California NorthX Biologics and Demeetra Launch Integrated CLD-to-GMP Collaboration for Biologics Development Flamma Group Passes First FDA Inspection at Malvern, PA CDMO Site More CDMO News IDT Biologika, SK bioscience and Vaxxas Advance Needle-Free Influenza Vaccines for Europe Quotient Sciences Extends Commercial Supply Partnership with Ipsen for FOP Treatment Scinai Immunotherapeutics Secures NIS 5 Million IIA Grant to Expand Robotic Fill & Finish Platform Charles River Laboratories Updates 2026 Guidance Following Planned Divestitures Cellipont Bioservices and Soter Bio Launch U.S.-Based Integrated RNA-to-Cell Therapy Platform C-Ray Therapeutics Achieves AAALAC Full Accreditation for Radiopharmaceutical CRDMO Facility AtomVie Global Radiopharma Supplies First Patient Dose in Phase 1/2a Study of 177Lu-BetaBart (RV-01) Avid Bioservices Opens 78,000 Square Foot Early Phase Center of Excellence in California NorthX Biologics and Demeetra Launch Integrated CLD-to-GMP Collaboration for Biologics Development Flamma Group Passes First FDA Inspection at Malvern, PA CDMO Site More CDMO News SPOTLIGHT How Are You and Your Peers Navigating Pharma Manufacturing in 2026? [Survey] Ophtapharm in 60 Seconds Watch Now RESOURCES How CDMO Pricing Works [Download] AI + Digital Maturity in Contract Manufacturing: CDMO Benchmarking Report North American CDMO Landscape 2025 [Infographic]